HST Global, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020
April 14, 2021 at 06:31 am EDT
Share
HST Global, Inc. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced operating loss was USD 207,978 compared to USD 151,554 a year ago. Net loss was USD 208,992 compared to net income of USD 426,572 a year ago. Basic loss per share from continuing operations was USD 0.04 compared to basic earnings per share from continuing operations of USD 0.13 a year ago.
HST Global, Inc. is an integrated health and wellness biotechnology company. The Company is focused on developing and /or acquiring a network of wellness centers worldwide that is primarily focused on the homeopathic and alternative treatment of late-stage cancer. The Company intends to acquire innovative products for the treatment of life-threatening diseases. The Company primarily focuses on homeopathic and alternative product candidates that are undergoing or have already completed clinical testing for the treatment of late-stage cancer and/or life-threatening diseases. The Company has not generated any revenue.
HST GLOBAL, INC. 
